MedPath

Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy

Not Applicable
Conditions
Magnetic Resonance Imaging
Ovarian Function
Menstruation
Interventions
Procedure: transvaginal surgery;UAE and D&C
Registration Number
NCT02933190
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Brief Summary

To investigate the fertility in patients after treatment by transvaginal surgery or uterine artery embolization combined with uterine curettage

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • increased levels of serum β-hCG and ultrasonography findings. The criteria for diagnosis by ultrasonography was the presence of the following: (1) an empty uterine cavity and endocervical canal; (2) detection of the placenta and/or a gestational sac embedded in the hysterectomy scar; (3) the presence of the gestation sac with or without a fetal pole and with or without fetal cardiac activity (depending on the gestational age) in the anterior part of the uterine isthmus; and (4) a thin (1-3 mm) or absent myometrial layer between the gestational sac and the bladder(24). All patients had taken Magnetic Resonance Imaging (MRI) to clarify the diagnosis . Pregnancy tissues were identified by histopathology examinations of the surgical tissues.
Read More
Exclusion Criteria
  • All enrolled patients had no contraindications for transvaginal surgery or UAE, including renal failure, active pelvic infection, clotting disorders, or known allergy to the contrast material.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CSP;transvaginal surgery;UAE and D&Ctransvaginal surgery;UAE and D&CCesarean scar pregnancy (CSP) refers to the implantation of a gestational sac with the myometrium at the site of a previous cesarean scar
Primary Outcome Measures
NameTimeMethod
Duration of menstruation by questionnaire (days)six months after treatment
Endocrine level by blood examination (FSH in IU/L)six months after treatment
Volume of menstruation by questionnaire (in pictorial blood loss score)six months after treatment
Secondary Outcome Measures
NameTimeMethod
The length of the CSD by MRI (millimeter)six months after treatment
The depth of the CSD by MRI (millimeter)six months after treatment
The width of the CSD by MRI (millimeter)six months after treatment

Trial Locations

Locations (1)

Department of Gynecology, Shanghai First Maternity and Infant Hospital, affiliated to Tongji University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath